Utah Medical Products, Inc. (UTMD)

NASDAQ: UTMD · Real-Time Price · USD

72.12

+0.12 (0.17%)

At close: Aug 19, 2026, 4:00 PM EDT

72.50

+0.38 (0.52%)

After-hours: Aug 19, 2026, 7:30 PM EDT

Utah Medical Products Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	36.11	38.52	40.9	50.22	52.28	49.05
Revenue Growth	-7.00%	-5.83%	-18.56%	-3.94%	6.58%	16.30%
Gross Profit	20.91	22	24.14	30.04	32.2	30.92
Operating Income	11.97	12.76	15.73	16.78	19.79	18.88
Net Income	10.49	11.29	13.87	16.64	16.47	14.79
Earnings Per Share	3.28	3.48	3.96	4.57	4.52	4.04
EPS Growth	-12.36%	-12.06%	-13.33%	1.11%	11.88%	37.41%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	22.04	22.76	23.87	30.41	34.52	31.76
Europe	-	7.93	8.71	8.92	7.21	7.43
Other	-	7.83	8.33	10.89	10.54	9.86
Total	36.11	38.52	40.9	50.22	52.28	49.05

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	87.53	85.76	82.98	92.87	75.05	60.97
Total Debt	0.2	0.29	0.28	0.3	0.34	0.4
Net Cash (Debt)	87.33	85.47	82.69	92.57	74.71	60.58
Net Cash Growth	6.60%	3.36%	-10.67%	23.91%	23.33%	18.19%
Net Cash Per Share	27.35	26.38	23.61	25.45	20.51	16.55

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	11.85	14.69	14.83	22.28	21.15	21.2
Capital Expenditures	-0.4	-0.37	-0.23	-0.64	-0.81	-0.55
Free Cash Flow	11.45	14.32	14.6	21.64	20.34	20.65
Free Cash Flow Growth	-17.03%	-1.92%	-32.53%	6.41%	-1.52%	7.13%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	57.90%	57.12%	59.03%	59.81%	61.58%	63.03%
Operating Margin	33.15%	33.12%	38.46%	33.40%	37.85%	38.49%
Pretax Margin	35.68%	36.63%	41.08%	40.00%	39.52%	38.86%
Profit Margin	29.04%	29.30%	33.92%	33.12%	31.51%	30.15%
FCF Margin	31.70%	37.18%	35.70%	43.09%	38.90%	42.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	1.240	1.225	1.205	1.185	1.165	0.855
Dividend Per Share Growth	1.64%	1.66%	1.69%	1.72%	36.26%	-23.66%
Dividend Yield	1.72%	2.21%	2.02%	1.48%	1.23%	0.92%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	21.97	15.89	15.03	18.38	22.14	24.69
Forward PE	-	17.80	17.80	17.80	17.80	17.80
P/FCF Ratio	20.06	12.52	14.28	14.12	17.93	17.68
PS Ratio	6.36	4.65	5.10	6.09	6.98	7.44